AMILORIDE TREATMENT AMELIORATES MRI SURROGATE MARKERS OF NEURODEGENERATION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

Eitemau Tebyg

• ASIC1 Blockade in Primary Progressive Multiple Sclerosis: Evidence of Neuroprotection with Amiloride
  gan: Arun, T, et al.
  Cyhoeddwyd: (2013)
• Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride
  gan: Arun, T, et al.
  Cyhoeddwyd: (2013)
• Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
  gan: Arun, T, et al.
  Cyhoeddwyd: (2013)
• AMILORIDE CLINICAL TRIAL IN OPTIC NEURITIS: TRIAL PARADIGM
  gan: McKee, J, et al.
  Cyhoeddwyd: (2014)
• COMPARING MRI MEASURES OF MYELIN INTEGRITY AS SURROGATE MARKERS FOR THE CLINICAL EXPRESSION OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
  gan: Matthews, L, et al.
  Cyhoeddwyd: (2010)